Advertisement
Screener

EVOKE PHARMA, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

EVOKE PHARMA, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

EVOKE PHARMA, INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$2.82 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-05-14

  • EVOKE PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$2.82M.
  • EVOKE PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-12-31 was -$2.73M.
  • EVOKE PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$2.20M.
  • EVOKE PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$2.10M.
  • EVOKE PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$8.72M.
  • EVOKE PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$8.71M.
  • EVOKE PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$10.50M.
  • EVOKE PHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$11.50M.
Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month
2018-03-31-$2.82M
10-Q · filed 2018-05-14
-$5.55M
derived: sum of 2 quarters · filed 2018-05-14
-$7.75M
derived: sum of 3 quarters · filed 2018-05-14
-$9.85M
derived: sum of 4 quarters · filed 2018-05-14
2017-12-31-$2.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07
-$4.93M
derived: sum of 2 quarters · filed 2018-03-07
-$7.03M
derived: sum of 3 quarters · filed 2018-03-07
-$8.72M
10-K · filed 2018-03-07
2017-09-30-$2.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$4.30M
derived: sum of 2 quarters · filed 2017-11-14
-$5.98M
10-Q · filed 2017-11-14
-$7.35M
derived: sum of 4 quarters · filed 2018-05-14
2017-06-30-$2.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$3.78M
10-Q · filed 2017-08-14
-$5.15M
derived: sum of 3 quarters · filed 2018-05-14
-$7.57M
derived: sum of 4 quarters · filed 2018-05-14
2017-03-31-$1.69M
10-Q · filed 2018-05-14
-$3.06M
derived: sum of 2 quarters · filed 2018-05-14
-$5.47M
derived: sum of 3 quarters · filed 2018-05-14
-$7.70M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31-$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07
-$3.79M
derived: sum of 2 quarters · filed 2018-03-07
-$6.02M
derived: sum of 3 quarters · filed 2018-03-07
-$8.71M
10-K · filed 2018-03-07
2016-09-30-$2.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$4.65M
derived: sum of 2 quarters · filed 2017-11-14
-$7.34M
10-Q · filed 2017-11-14
-$9.79M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30-$2.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$4.92M
10-Q · filed 2017-08-14
-$7.37M
derived: sum of 3 quarters · filed 2017-08-14
-$9.88M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31-$2.69M
10-Q · filed 2017-05-15
-$5.14M
derived: sum of 2 quarters · filed 2017-05-15
-$7.65M
derived: sum of 3 quarters · filed 2017-05-15
-$10.19M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31-$2.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
-$4.96M
derived: sum of 2 quarters · filed 2017-03-15
-$7.50M
derived: sum of 3 quarters · filed 2017-03-15
-$10.50M
10-K · filed 2017-03-15
2015-09-30-$2.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$5.05M
derived: sum of 2 quarters · filed 2016-11-09
-$8.04M
10-Q · filed 2016-11-09
-$10.56M
derived: sum of 4 quarters · filed 2016-11-09
2015-06-30-$2.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
-$5.54M
10-Q · filed 2016-08-15
-$8.06M
derived: sum of 3 quarters · filed 2016-08-15
-$11.97M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31-$3.00M
10-Q · filed 2016-05-11
-$5.52M
derived: sum of 2 quarters · filed 2016-05-11
-$9.43M
derived: sum of 3 quarters · filed 2016-05-11
-$12.50M
derived: sum of 4 quarters · filed 2016-05-11
2014-12-31-$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
-$6.43M
derived: sum of 2 quarters · filed 2016-03-10
-$9.50M
derived: sum of 3 quarters · filed 2016-03-10
-$11.50M
10-K · filed 2016-03-10
2014-09-30-$3.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$6.98M
derived: sum of 2 quarters · filed 2015-11-12
-$8.98M
10-Q · filed 2015-11-12
-$10.87M
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30-$3.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
-$5.07M
10-Q · filed 2015-08-13
-$6.96M
derived: sum of 3 quarters · filed 2015-08-13
-$7.23M
derived: sum of 4 quarters · filed 2015-08-13
2014-03-31-$2.00M
10-Q · filed 2015-05-14
-$3.89M
derived: sum of 2 quarters · filed 2015-05-14
-$4.16M
derived: sum of 3 quarters · filed 2015-05-14
2013-12-31-$1.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04
-$2.16M
derived: sum of 2 quarters · filed 2015-03-04
-$3.04M
10-K · filed 2015-03-04
2013-09-30-$274.68K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
-$1.15M
10-Q · filed 2014-11-13
2013-06-30-$876.32K
10-Q · filed 2014-08-13